Cue Biopharma, Inc.
Holding change · SEC EDGAR
This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
insider.holding_change
Occurred
2026-07-30
Reported
2026-08-03
Disclosure lag
4 days
Context
links are based on the recorded entity type| Field | Recorded value |
|---|---|
| Entity | Cue Biopharma, Inc. |
| Source | SEC EDGAR ↗ |
| Source identifier | 0001320383-26-000006 |
| Event ID | #279532 |
Recorded payload
JSON payload as stored after parsing{
"accession": "0001320383-26-000006",
"acquired_disposed": "A",
"code": "A",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "Cue Biopharma, Inc.",
"label": "Grant or award",
"person_name": "Ahlers James M",
"price": 0,
"role": "Chief Financial Officer",
"security": "Common Stock",
"shares": 25500,
"shares_owned_after": 25500,
"source_path": "edgar/data/1320383/0001320383-26-000006.txt",
"ticker": "CUE",
"value": null
}Source: Open recorded SEC filing
Source: SEC EDGAR · as of 2026-08-03T00:00:00Z